ILT-4
Showing 1 - 25 of >10,000
Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Paclitaxel
- +4 more
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital ( Site 3700)
Jan 31, 2023
Esophageal Squamous Cell Carcinoma (ESCC) Trial in Japan, Taiwan (Pembrolizumab, Coformulation favezelimab/pembrolizumab,
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- Pembrolizumab
- +5 more
-
Milan, Lombardia, Italy
- +13 more
Jan 3, 2023
AML M4, AML M5 Trial in Hangzhou (anti-ILT3 CAR-T)
Recruiting
- AML M4
- AML M5
- anti-ILT3 CAR-T
-
Hangzhou, Zhejiang, ChinaZhejiang Provincal People's Hospital
Mar 19, 2021
Allergic Rhinoconjunctivitis to Birch Pollen, With a Positive Skin Prick Test to Birch Pollen Trial in Paris (ILT-101 ld-(IL2))
Completed
- Allergic Rhinoconjunctivitis to Birch Pollen
- With a Positive Skin Prick Test to Birch Pollen
- ILT-101 ld-(IL2)
-
Paris, FranceCIC Paris Est GH Pitié Salpétrière
Dec 13, 2022
Healthy Volunteers Trial in Paris (ILT101, Placebo)
Completed
- Healthy Volunteers
- ILT101
- Placebo
-
Paris, FranceClinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021
Malignant Tumor Trial in United Kingdom, United States (Novilase Interstitial Laser Therapy)
Active, not recruiting
- Malignant Tumor
- Novilase Interstitial Laser Therapy
-
Tucson, Arizona
- +11 more
Mar 1, 2021
Covid19 Trial in Suresnes (Baseline and during hospitalization blood samples, Baseline blood sample)
Completed
- Covid19
- Baseline and during hospitalization blood samples
- Baseline blood sample
-
Suresnes, FranceFoch hospital
Aug 2, 2022
Liver Fibrosis and Steatosis in Adult US
Not yet recruiting
- Liver Fibrosis
- Fatty Liver
- iLivTouch
- FibroScan
-
Redwood City, California
- +3 more
Sep 20, 2023
Abdominal Aortic Aneurysms Trial in Canada, United States (ViTAA Analysis)
Recruiting
- Abdominal Aortic Aneurysms
- ViTAA Analysis
-
Birmingham, Alabama
- +6 more
Feb 22, 2022
Bipolar Depression Trial in Créteil (ILT101, Placebos)
Recruiting
- Bipolar Depression
- ILT101
- Placebos
-
Créteil, Hôpital Albert Chenevier, FrancePr Marion Leboyer
Dec 10, 2021
COVID 19 Trial in Paris (1: ILT101, 2: Placebo Comparator)
Completed
- COVID 19
- 1: ILT101
- 2: Placebo Comparator
-
Paris, FranceService Anesthésie Réanimation - Groupe Hospitalier Pitié-Salpêt
Oct 1, 2021
Origin of CEC in Patients After Allo-HSCT
Completed
- Graft Versus Host Disease, Acute
- +2 more
- D-CEC counting
-
Brescia, ItalyASST Spedali Civili di Brescia
Jul 7, 2020
Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus Trial in Paris, Villejuif, Créteil (Interleukin 2)
Completed
- Rheumatoid Arthritis
- +13 more
- Interleukin 2
-
Paris, Ile De France, France
- +10 more
Jul 19, 2021
Type 1 Diabetes Trial in Worldwide (rhIL-2, Placebo)
Active, not recruiting
- Type 1 Diabetes
- rhIL-2
- Placebo
-
Liège, Province De Liège, Belgium
- +33 more
Feb 9, 2022
Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)
Recruiting
- Colorectal Cancer
- +2 more
- Sanprobi IBS®
-
Kościerzyna, PolandUnit of Surgery with Unit of Oncological Surgery in Koscierzyna
Aug 24, 2023
Idiopathic Parkinson Disease Trial (MRx0029, MRx0005)
Withdrawn
- Idiopathic Parkinson Disease
- MRx0029
- MRx0005
- (no location specified)
Apr 19, 2023
Sleep, Mood, Caffeine Withdrawal Trial in Santa Monica (Clevr Sleeptime, Clevr Matcha, Clevr Chai)
Active, not recruiting
- Sleep
- +4 more
- Clevr Sleeptime
- +2 more
-
Santa Monica, CaliforniaCitruslabs
Nov 19, 2023
Oral Lichen Planus Trial in Cairo (Probiotic Blend Oral capsules, Corticosteroids for Local Oral Treatment)
Recruiting
- Oral Lichen Planus
- Probiotic Blend Oral capsules
- Corticosteroids for Local Oral Treatment
-
Cairo, EgyptCairo University
Nov 5, 2023
Stress, Anxiety, Autonomic Dysregulation Trial in Winston-Salem (Cereset Research)
Not yet recruiting
- Stress
- +5 more
- Cereset Research
-
Winston-Salem, North CarolinaAtrium Wake Forest Baptist Health
Aug 8, 2023